Literature DB >> 19411171

MicroRNAs and cancer--new paradigms in molecular oncology.

Massimo Negrini1, Milena S Nicoloso, George A Calin.   

Abstract

The 'classic' view of molecular oncology indicates that cancer is a genetic disease involving tumor suppressor and oncogenic proteins. However, in the recent years, it has been demonstrated that small regulatory non-coding RNAs (ncRNAs) named microRNAs (miRNAs) are involved in human tumorigenesis, thus revealing a new layer in the molecular architecture of human cancer. Gene expression studies revealed that hundreds of miRNAs are deregulated in cancer cells and functional studies clarified that miRNAs are involved in all the molecular and biological processes that drive tumorigenesis. Here, we summarize the recent advances in miRNA involvement in human cancer and illustrate the benefits of using these knowledge for medical practice. New diagnostic classifiers based on miRNAs will soon be available for medical practitioners and, even more importantly, miRNAs may become novel anti-cancer tools.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411171     DOI: 10.1016/j.ceb.2009.03.002

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  108 in total

1.  Whole mouse blood microRNA as biomarkers for exposure to γ-rays and (56)Fe ion.

Authors:  Thomas Templin; Sally A Amundson; David J Brenner; Lubomir B Smilenov
Journal:  Int J Radiat Biol       Date:  2011-01-28       Impact factor: 2.694

2.  Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease.

Authors:  Hong Zhi; Lina Wang; Genshan Ma; Xingzhou Ye; Xiaojin Yu; Yi Zhu; Yu Zhang; Jiaju Zhang; Bei Wang
Journal:  Clin Res Cardiol       Date:  2011-12-11       Impact factor: 5.460

Review 3.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

Review 4.  Cross talk between microRNA and coding cancer genes.

Authors:  Tanja Kunej; Irena Godnic; Simon Horvat; Minja Zorc; George A Calin
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

5.  Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage.

Authors:  Subrata Haldar; Aruna Basu
Journal:  Mol Cell Pharmacol       Date:  2011-01-01

6.  miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition.

Authors:  Kazuhiro Yachi; Masumi Tsuda; Shinji Kohsaka; Lei Wang; Yoshitaka Oda; Satoshi Tanikawa; Yusuke Ohba; Shinya Tanaka
Journal:  Signal Transduct Target Ther       Date:  2018-12-28

Review 7.  Metastamir: the field of metastasis-regulatory microRNA is spreading.

Authors:  Douglas R Hurst; Mick D Edmonds; Danny R Welch
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

8.  Effect of intravenous injection of antagomiR-1 on brain ischemia.

Authors:  Anis Talebi; Mehdi Rahnema; Mohammad Reza Bigdeli
Journal:  Mol Biol Rep       Date:  2019-02-01       Impact factor: 2.316

Review 9.  MicroRNA and cancer chemoprevention.

Authors:  Bin Yi; Gary A Piazza; Xiulan Su; Yaguang Xi
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26

Review 10.  MicroRNA assassins: factors that regulate the disappearance of miRNAs.

Authors:  Zoya S Kai; Amy E Pasquinelli
Journal:  Nat Struct Mol Biol       Date:  2010-01       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.